close
close

Jupiter Life Line Hospitals Q1 2025 Earnings: Earnings per share: ₹6.80 (vs. ₹9.93 in Q1 2024)


Jupiter Life Line Hospitals Q1 2025 Earnings: Earnings per share: ₹6.80 (vs. ₹9.93 in Q1 2024)

Jupiter Life Line Hospitals (NSE:JLHL) Q1 2025 Results

Key financial results

  • Revenue: ₹2.95 billion (up 19% from Q1 2024).
  • Net income: ₹446.1 million (down 17% from Q1 2024).
  • Profit margin: 15% (compared to 22% in Q1 2024). The margin decline is due to higher expenses.
  • Earnings per share: ₹6.80 (vs. ₹9.93 in Q1 2024).
Profit and sales growth
NSEI:JLHL Earnings and Revenue Growth August 12, 2024

All figures shown in the graph above refer to the last 12 months (TTM)

Insights into Jupiter Life Line Hospitals’ results

An average revenue growth of 14% per annum is expected for the next three years. In contrast, growth of 17% is forecast for the Indian healthcare sector.

Performance of Indian healthcare industry.

The company’s shares fell 1.1 percent compared to the previous week.

Balance sheet analysis

Although it is very important to consider the income statement, you can also learn a lot about a company by looking at its balance sheet. We have a graphical representation of Jupiter Life Line Hospitals’ balance sheet and an in-depth analysis of the company’s financial position.

New: Manage all your stock portfolios in one place

We have the the ultimate portfolio companion for stock investors, and it’s free.

• Connect an unlimited number of portfolios and see your total amount in one currency
• Be notified of new warning signals or risks by email or mobile phone
• Track the fair value of your stocks

Try a demo portfolio for free

Do you have feedback on this article? Are you concerned about the content? Contact us directly from us. Alternatively, send an email to editorial-team (at) simplywallst.com.

This Simply Wall St article is of a general nature. We comment solely on the basis of historical data and analyst forecasts, using an unbiased methodology. Our articles do not constitute financial advice. It is not a recommendation to buy or sell any stock and does not take into account your objectives or financial situation. Our goal is to provide you with long-term analysis based on fundamental data. Note that our analysis may not take into account the latest price-sensitive company announcements or qualitative materials. Simply Wall St does not hold any of the stocks mentioned.

Leave a Reply

Your email address will not be published. Required fields are marked *